Ahmet Doğukan BAYRAK

Dr. Ahmet Doğukan BAYRAK

Infectious Diseases and Clinical Microbiology, Şişli Etfal Eğitim ve Araştırma Hastanesi, Istanbul, İstanbul, Turkey (Türkiye)
orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 January 2024 in Antibiotics
Verified
Journal Article
Open access
PDF file
Okan DerinOkan Derin
Okan Derin
MSMeyha Sahin
Meyha Sahin
RDRıdvan Dumlu
Rıdvan Dumlu
SBSedef Başgönül
Sedef Başgönül
ABAhmet Doğukan BAYRAK
Ahmet Doğukan BAYRAK
AMAli Mert
Ali Mert
Background: Managing Pseudomonas aeruginosa bloodstream infections (BSIs) is challenging due to increasing antimicrobial resistance, limited therapeutic options, and high mortality rates. In this study, we aimed to identify 30-day mortality risk factors and assess infectious diseases consultants’ preferences for combination or monotherapy. Methods: The study was conducted in four hospitals in Istanbul, Turkey, involving 140 adult ICU beds and 336,780 ICU-bed-days between 1 January 2014, and 31 December 2021. A total of 157 patients were included in the study. Cox proportional hazard regression was performed to assess the factors on 30-day mortality. Results: The 30-day mortality rate was 44.6% (70/157). Higher Charlson Comorbidity Index (CCI) score, severe sepsis, primary bloodstream infection, being in COVID-19 pandemic period, and infection caused by MDR strain were associated with higher hazard of 30-day mortality. Combination therapy was more commonly used in patients with BSIs with MDR or DTR (difficult-to-treat) strains but did not significantly improve the hazard of 30-day mortality. Conclusions: Targeted interventions and vigilant management strategies are crucial for patients with defined risk factors. While infectious disease consultants tended to favor combination therapy, particularly for drug-resistant strains, our analysis revealed no significant impact on 30-day mortality hazard. The increased incidence of P. aeruginosa BSIs during the pandemic emphasizes the need for infection control measures and appropriate antibiotic prescribing practices.

6 May 2026 in Journal of Investigative Medicine
Verified
Journal Article
Closed access
ODOlcay Dilken
Olcay Dilken
ABAhmet Doğukan BAYRAK
Ahmet Doğukan BAYRAK
Okan DerinOkan Derin
Okan Derin
UTUğur Tekbaş
Uğur Tekbaş
MAmustafa altınay
mustafa altınay
SDSerpil Kılıç Depren
Serpil Kılıç Depren
Early identification of gram-negative bacteremia (GN-BSI) in intensive care units (ICUs) remains challenging at the time of blood culture sampling, when clinical signs are often nonspecific and existing diagnostic approaches typically rely on single-timepoint measurements. We conducted a retrospective cohort study of adult ICU patients admitted between July 2022 and January 2024 to investigate whether short-term longitudinal patterns in routinely collected clinical and laboratory data contain diagnostically relevant information for GN-BSI. Clinical and laboratory variables were extracted at three consecutive timepoints (Day −2, −1, and 0 relative to blood culture collection), and diagnostic models incorporating this temporal information were developed using complementary statistical and machine-learning approaches. Model performance was evaluated on a held-out test set using discrimination, calibration, and decision curve analysis. Among 568 patients, models incorporating short-term longitudinal data demonstrated good and consistent discrimination for GN-BSI (AUC range 0.81–0.83). A parsimonious logistic regression model of the mean values of seven predictors achieved an AUC of 0.81, which was not significantly different from the best-performing machine learning model (MILD-SVM, AUC 0.83; bootstrap test, p = 0.728). Diagnostic performance was stable across modeling approaches, indicating robustness of the underlying signal rather than dependence on a specific algorithm. Decision curve analysis suggested a higher net benefit of model-based risk stratification compared with treat-all or treat-none strategies across clinically relevant threshold probabilities. Central venous catheter presence, prior antibiotic use, hemoglobin, creatinine, and albumin consistently emerged as influential predictors. These findings indicate that short-term longitudinal clinical trajectories contain diagnostically meaningful information for GN-BSI at the time of blood culture sampling and support further external validation and prospective evaluation prior to clinical implementation.

14 September 2026 in npj Digital Medicine
Verified
Journal Article
Open access
PDF file
ABAhmet Doğukan BAYRAK
Ahmet Doğukan BAYRAK
ODOlcay Dilken
Olcay Dilken
GÇGizem Çamkerten
Gizem Çamkerten
HTHakkı Meriç Türkkan
Hakkı Meriç Türkkan
CTCeren Atasoy Tahtasakal
Ceren Atasoy Tahtasakal
Okan DerinOkan Derin
Okan Derin
Bacteremia is a life-threatening infection requiring early diagnosis and timely treatment. Although machine learning (ML)–based models may support early clinical decision-making, their validity remains uncertain. We prospectively validated ML-based models developed at our center for predicting Gram-negative bacteremia and compared their performance with established clinical scores. This observational study included adult ICU patients hospitalized for ≥48 h who met Sepsis-3 criteria for suspected infection between February and July 2025. Clinical and laboratory data from the preceding 48 h were analyzed. Gram-negative bacteremia was identified in 97 of 289 blood cultures. Several clinical scores were significantly associated with bacteremia. While ML models demonstrated modest discrimination in cohort, performance improved to a moderate level (AUROC ≈ 0.70) with higher sensitivity in a post-hoc subgroup analysis of cultures obtained between ICU days 4 and 10. These findings highlight the importance of patient stratification and culture selection when validating predictive models in clinical settings.

19 June 2026 in Journal of Intensive Care Medicine
Verified
Journal Article
Closed access
HTHakkı Meriç Türkkan
Hakkı Meriç Türkkan
UÖUmut Özgür
Umut Özgür
ODOlcay Dilken
Olcay Dilken
ABAhmet Doğukan BAYRAK
Ahmet Doğukan BAYRAK
Okan DerinOkan Derin
Okan Derin
Background: Accurate assessment of organ dysfunction is essential for risk stratification in critically ill patients. The traditional Sequential Organ Failure Assessment score (SOFA-1) is widely used but reflects clinical practices from the 1990s. The updated SOFA-2 incorporates revised thresholds aligned with current organ-support strategies; however, its prognostic performance in infection-focused intensive care unit (ICU) populations remains uncertain. We compared SOFA-1 and SOFA-2 for predicting 28-day mortality in ICU patients undergoing blood culture acquisition ≥48 h after admission. Methods: We conducted a retrospective cohort study of adult ICU patients who underwent blood culture sampling ≥48 h after ICU admission between June 2022 and August 2024. SOFA-1 and SOFA-2 scores were calculated at the time of index blood culture. Mortality prediction was assessed using receiver operating characteristic analysis with paired DeLong comparisons. Associations with 28-day mortality were examined using logistic regression and Cox proportional hazards models adjusted for age and comorbidity burden. Clinical utility was evaluated using decision curve analysis. Results: Among 403 patients, 28-day mortality was 54%. SOFA-2 scores were lower than SOFA-1 in 70% of patients, resulting in frequent downward reclassification across severity strata. Discriminative performance for 28-day mortality was similar for SOFA-1 and SOFA-2 (AUC 0.707 vs 0.700; ΔAUC = 0.007; p = .031). Calibration and net clinical benefit were comparable between scores. In adjusted time-to-event analyses, only the very severe category (>10) was independently associated with mortality in both scoring systems, with a numerically higher hazard ratio for SOFA-2. Conclusions: In this infection-triggered ICU cohort, SOFA-2 did not demonstrate consistent prognostic superiority over SOFA-1 for 28-day mortality prediction. Despite systematic score redistribution, overall discrimination and clinical utility were similar, with any apparent advantage of SOFA-2 confined to the highest-risk subgroup. Further validation in infection-enriched ICU populations is warranted.

13 August 2026 in Antibiotics
Verified
Journal Article
Open access
PDF file
ABAhmet Doğukan BAYRAK
Ahmet Doğukan BAYRAK
Okan DerinOkan Derin
Okan Derin
Background: AmpC β-lactamases are complex resistance determinants due to inducible chromosomal expression, stable derepression, plasmid-mediated dissemination, potential for co-resistance, and diagnostic interpretation challenges. Nevertheless, the scientific production, citation structure, and thematic evolution of the AmpC β-lactamase literature have not been comprehensively mapped. This study aimed to evaluate this literature using bibliometric methods. Methods: Original articles and reviews indexed in SCI-E and ESCI within the Web of Science Core Collection were evaluated when “AmpC” appeared in the title field. After an additional microbiological filter, 1183 documents published between 1980 and 2026 were included. Analyses were performed using R, bibliometrix, and Biblioshiny. Results: Scientific production increased from the 2000s onward. Antimicrobial Agents and Chemotherapy and Journal of Antimicrobial Chemotherapy were among the most productive and most locally cited sources, while the United States ranked first in publication output and total citation impact. The most frequent keywords were Escherichia coli, ESBL, Klebsiella pneumoniae, and Enterobacterales. Conceptual analyses showed that the literature was structured around chromosomal AmpC biology, plasmid-mediated dissemination, resistance ecology intersecting with ESBLs, a cluster interpretable as a One Health axis, and clinical management themes. Trend topic analysis showed that multidrug resistance, carbapenemase, and virulence have become more visible in recent years. Conclusions: AmpC β-lactamase literature has broadened from an earlier emphasis on chromosomal resistance biology toward a multidimensional research field encompassing plasmid-mediated dissemination, resistance ecology, One Health-related themes, and clinical management. The recent prominence of concepts related to multidrug resistance phenotypes, the concurrent dissemination of resistance determinants, and pathogen virulence may suggest that the field is increasingly being addressed within a broader antimicrobial resistance context.